• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳化剂对固体脂质纳米粒结晶的影响。

Influence of emulsifiers on the crystallization of solid lipid nanoparticles.

作者信息

Bunjes Heike, Koch Michel H J, Westesen Kirsten

机构信息

Friedrich-Schiller-Universität Jena, Institute of Pharmacy, Department of Pharmaceutical Technology, Lessingstrasse 8, 07743 Jena, Germany.

出版信息

J Pharm Sci. 2003 Jul;92(7):1509-20. doi: 10.1002/jps.10413.

DOI:10.1002/jps.10413
PMID:12820155
Abstract

The crystallization temperature and polymorphism of tripalmitin nanoparticles in colloidal dispersions prepared by melt-homogenization and stabilized with different pharmaceutical surfactants (sodium glycocholate, sodium oleate, tyloxapol, Solutol HS 15, Cremophor EL) and their combinations with soybean phospholipid (Lipoid S100) were investigated to establish the influence of the emulsifiers on these parameters. There were no major effects on the crystallization temperature but remarkable differences in the time-course of polymorphic transitions after crystallization of the triglyceride particles indicate interaction between the surfactant layer and the triglyceride matrix. The metastable alpha-modification was most stable in dispersions solely stabilized with glycocholate. Upon fast cooling from the melt, these dispersions form an uncommon type of alpha-modification that displays only a very weak small-angle reflection indicating poor ordering between triglyceride layers. Slow crystallization of these glycocholate-stabilized nanoparticles yields the usual alpha-form. Electron microscopic investigations reveal that, in both cases, the particles in the alpha-modification are less anisometric than those of the stable beta-form. These results indicate that major rearrangements still may take place in solid lipid nanoparticles after recrystallization.

摘要

研究了通过熔融均质法制备并用不同药用表面活性剂(甘氨胆酸钠、油酸钠、聚乙氧基月桂醇、聚乙二醇单硬脂酸酯HS 15、聚氧乙烯蓖麻油EL)及其与大豆磷脂(Lipoid S100)的组合稳定的胶体分散体中三棕榈酸甘油酯纳米颗粒的结晶温度和多晶型,以确定乳化剂对这些参数的影响。对结晶温度没有重大影响,但甘油三酯颗粒结晶后多晶型转变的时间进程存在显著差异,这表明表面活性剂层与甘油三酯基质之间存在相互作用。亚稳α-晶型在仅用胆酸盐稳定的分散体中最稳定。从熔体快速冷却时,这些分散体形成一种不常见的α-晶型,其仅显示非常弱的小角反射,表明甘油三酯层之间的有序性较差。这些胆酸盐稳定的纳米颗粒缓慢结晶会产生常见的α-晶型。电子显微镜研究表明,在这两种情况下,α-晶型的颗粒比稳定的β-晶型颗粒的各向异性更小。这些结果表明,重结晶后固体脂质纳米颗粒中仍可能发生重大重排。

相似文献

1
Influence of emulsifiers on the crystallization of solid lipid nanoparticles.乳化剂对固体脂质纳米粒结晶的影响。
J Pharm Sci. 2003 Jul;92(7):1509-20. doi: 10.1002/jps.10413.
2
Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification.聚乙烯醇作为乳化剂可稳定α-晶型的固体甘油三酯药物载体纳米颗粒。
Mol Pharm. 2009 Jan-Feb;6(1):105-20. doi: 10.1021/mp8000759.
3
Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles.饱和磷脂促进甘油三酯纳米颗粒的结晶,但减缓其多晶型转变。
J Control Release. 2005 Oct 3;107(2):229-43. doi: 10.1016/j.jconrel.2005.06.004.
4
Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles.稳定剂体系对过冷向列纳米粒子性质和相行为的影响。
J Colloid Interface Sci. 2010 Oct 1;350(1):229-39. doi: 10.1016/j.jcis.2010.06.018. Epub 2010 Jun 15.
5
Controlled polymorphic transformation of continuously crystallized solid lipid nanoparticles in a microstructured device: a feasibility study.微结构装置中连续结晶固体脂质纳米粒的可控多晶型转变:一项可行性研究
Eur J Pharm Biopharm. 2014 Apr;86(3):324-31. doi: 10.1016/j.ejpb.2013.08.009. Epub 2013 Aug 20.
6
Stability of the Metastable α-Polymorph in Solid Triglyceride Drug-Carrier Nanoparticles.固体甘油三酯药物载体纳米颗粒中亚稳态α-多晶型物的稳定性
Langmuir. 2015 Jun 23;31(24):6663-74. doi: 10.1021/acs.langmuir.5b00874. Epub 2015 Jun 9.
7
Evaluation of Shirasu Porous Glass (SPG) membrane emulsification for the preparation of colloidal lipid drug carrier dispersions.评价硅砂多孔玻璃(SPG)膜乳化法用于制备胶体脂质药物载体分散体。
Eur J Pharm Biopharm. 2014 May;87(1):178-86. doi: 10.1016/j.ejpb.2013.11.010. Epub 2013 Dec 9.
8
PEGylation of supercooled smectic cholesteryl myristate nanoparticles.超冷各向同性胆甾醇肉豆蔻酸纳米粒子的聚乙二醇化。
Eur J Pharm Biopharm. 2012 Jun;81(2):409-17. doi: 10.1016/j.ejpb.2012.03.011. Epub 2012 Apr 2.
9
Structural investigations on lipid nanoparticles containing high amounts of lecithin.对含有大量卵磷脂的脂质纳米颗粒的结构研究。
Eur J Pharm Sci. 2006 Feb;27(2-3):226-36. doi: 10.1016/j.ejps.2005.10.004. Epub 2005 Nov 17.
10
Preparation of nanoemulsions and solid lipid nanoparticles by premix membrane emulsification.通过预混膜乳化法制备纳米乳剂和固体脂质纳米粒。
J Pharm Sci. 2012 Jul;101(7):2479-89. doi: 10.1002/jps.23163. Epub 2012 Apr 23.

引用本文的文献

1
Quality by design approach for development and characterization of gabapentin-loaded solid lipid nanoparticles for intranasal delivery: , and histopathological evaluation.用于鼻内给药的加巴喷丁固体脂质纳米粒的设计质量开发与表征方法及组织病理学评价
Iran J Basic Med Sci. 2024;27(7):904-913. doi: 10.22038/IJBMS.2024.76281.16511.
2
Application of Advanced Emulsion Technology in the Food Industry: A Review and Critical Evaluation.先进乳液技术在食品工业中的应用:综述与批判性评价
Foods. 2021 Apr 9;10(4):812. doi: 10.3390/foods10040812.
3
Combination Therapy Using Low-Concentration Oxacillin with Palmitic Acid and Span85 to Control Clinical Methicillin-Resistant .
使用低浓度苯唑西林与棕榈酸和司盘85联合治疗以控制临床耐甲氧西林…… (原文似乎不完整)
Antibiotics (Basel). 2020 Oct 8;9(10):682. doi: 10.3390/antibiotics9100682.
4
Crystallization modifiers in lipid systems.脂质系统中的结晶改性剂。
J Food Sci Technol. 2015 Jul;52(7):3925-46. doi: 10.1007/s13197-014-1587-0. Epub 2014 Oct 11.
5
Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.用于脱发治疗的局部和透皮应用脂质纳米颗粒:开发、物理化学表征以及体外释放和渗透研究。
Int J Nanomedicine. 2014 Mar 7;9:1231-42. doi: 10.2147/IJN.S45561. eCollection 2014.
6
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.用于口服给药的脂质纳米粒(固体脂质纳米粒和纳米结构脂质载体)的当前技术水平与新趋势
J Drug Deliv. 2012;2012:750891. doi: 10.1155/2012/750891. Epub 2011 Nov 24.
7
Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.5-氟尿嘧啶固体脂质纳米粒的优化:治疗结肠癌的初步研究。
Int J Med Sci. 2010 Nov 22;7(6):398-408. doi: 10.7150/ijms.7.398.
8
Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation.由甘油酯脂质制成的依托泊苷纳米颗粒:制剂、表征、体外药物释放及稳定性评估。
AAPS PharmSciTech. 2005 Sep 30;6(2):E158-66. doi: 10.1208/pt060224.
9
Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies.具有不同表面电荷的依托泊苷包裹的三棕榈酸甘油酯纳米粒:制剂、表征、放射性标记及生物分布研究
AAPS J. 2004 Oct 7;6(3):e23. doi: 10.1208/aapsj060323.
10
Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs.过冷近晶相纳米颗粒:一种用于难溶性药物的潜在新型载体系统。
Pharm Res. 2004 Oct;21(10):1834-43. doi: 10.1023/b:pham.0000045237.46019.6e.